Events

November 21-23, 2019

Lawrence Vernetti, Keynote speaker at the 5th International Conference on Drug Discovery, Development and Lead Optimization, Boston, MA (Drug Discovery-2019).

October 15, 2019

Albert Gough presenting at the Organ on a Chip World Congress, San Diego, CA. “Development of the Microphysiology Systems Database for Sharing and Analyzing Data from Human Organ Models”

September 23, 2019

Albert Gough presenting at the 3rd Annual Charles River World Congress: Delivering Therapies to the Clinic Faster, Cambridge, MA. “Application of Human Liver Microphysiology Systems and the Microphysiology Systems Database to Experimental ADME-Tox and Disease Models”

September 4th to 6th, 2019

Lansing Taylor, PhD presenting at the 3D Tissue Models meeting, Boston, MA. “Non-Alcoholic Fatty Liver Disease (NAFLD) Drug Discovery Through the Application of Quantitative Systems Pharmacology and Microphysiology Systems”

August 22, 2019

Albert Gough presenting at Johnson Space Center, Houston, Tx. “Development of the Microphysiology Systems Database for Sharing and Analyzing Data from Human Organ Models”

August 21, 2019

Albert Gough presenting at the Technology Collaboration Center Data Analytics Workshop, Rice University, Houston TX. “Development of the Microphysiology Systems Database for Sharing and Analyzing Data from Human Organ Models”

June 21, 2019

Mark Miedel presenting at the 31st Annual UPMC Hillman Cancer Center Scientific Retreat and Satellite Conference, University of Pittsburgh. “Modeling the Effect of the Metastatic Microenvironment on Phenotypes Conferred by Clinically Relevant Estrogen Receptor Alpha Mutations Using a Human Liver Microphysiological System”

March 12, 2019

Lansing Taylor, PhD presenting at the SOT meeting, Baltimore, MD. “Application of a Microphysiology (MPS) Platform for Systems Toxicology”

December 4, 2018

Lansing Taylor, PhD presenting at the NCATS-NASA State of the Science Meeting. “3D Tissues and Microphysiological Systems”

November 20, 2018

Lansing Taylor, PhD presenting at Moderna, Boston, MA. “Application of Quantitative Systems Pharmacology (QSP) and Human Microphysiology Systems (MPS) to Develop Therapeutic Strategies for Liver

Diseases”

November 5th and 6th, 2018

Lansing Taylor, PhD presenting at the FNIH BC-CSB Symposium, Bethesda, Maryland. “Biologically Relevant Heterogeneity: Metrics and Practical Insights”

October 10th, 2018

Lansing Taylor, PhD presenting at the University of Miami, Miami, Florida. “Application of Quantitative Systems Pharmacology (QSP) to Develop Therapeutic Strategies for Liver Diseases”

September 13th-14th, 2018

Lansing Taylor, PhD presenting at an NIH workshop, Pittsburgh, Pennsylvania. “The Evolution of Human Experimental Models for Drug Discovery/Development and Precision medicine: Different Model Types, Reproducibility, Applications and Future Impact”

September 10, 2018

Lansing Taylor, PhD presenting at the University of North Carolina School of Pharmacy, Chapel Hill, North Carolina. “Application of Quantitative Systems Pharmacology (QSP) to Develop Therapeutic Strategies for Liver Diseases”

July 16th-18, 2018

Lansing Taylor, PhD presenting at the North American meeting of the International Society for the Study of Xenobiotics, Montreal, Canada. “A Human Liver Microphysiology System for Drug Discovery and

development”